Drug shows promise for starving out cancer cells
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a new study published in Science Advances.
May 6, 2024
0
26
Starving out tumor cells may be a promising therapy for treatment-resistant lung cancer, according to a new study published in Science Advances.
May 6, 2024
0
26
A team of University of Saskatchewan (USask) researchers are exploring the role of a newly identified cell type in cystic fibrosis (CF), which could lead to effective new types of treatment.
Apr 29, 2024
0
3
A new, Yale-led study suggests that a range of respiratory viral infections—including COVID-19 and influenza—may be preventable or treatable with a generic antibiotic that is delivered to the nasal passageway.
Apr 22, 2024
0
99
The most common type of lung fibrosis—scarring of the lungs—is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis (IPF) and related lung ...
Apr 12, 2024
0
7
TinyTrach, a team of interdisciplinary engineering students from Rice University, has created an innovative pediatric endotracheal tube (ETT) integrated with a camera and anchoring system that could make intubation procedures ...
Apr 11, 2024
0
0
A simple screening tool integrated into the admissions process for critically ill patients can streamline requests for palliative care consultations, according to a study published in Critical Care Nurse (CCN).
Apr 1, 2024
0
0
Worldwide, approximately 4.5 million people die of traumatic injury every year. Many of these patients die from blood loss.
Mar 26, 2024
0
0
For hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published online March 11 in Intensive Care Medicine.
Mar 21, 2024
0
0
Inhaling nontuberculous mycobacteria is common for most people. The bacteria are found in water systems, soil and dust worldwide and, for many, cause no harm.
Mar 14, 2024
1
56
Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study ...
Mar 6, 2024
0
0